// App-Quantinova.ai

2063 : Improved sensitivity and in vitro efficacy of RGD grafted PEGylated gemcitabine liposomes in RRM1 siRNA pretreated cancer cells

Researchers

Presenter

  • Rohan A. Lalani

Principal Investigators

  • Priyanka Bhatt

  • Mohan Rathi

  • Ambikanandan Misra

Medical Centers

  • The Maharaja Sayajirao University of Baroda, Vadodra, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Ribonucleotide Reductase Catalytic Subunit M1

Drug/Treatment

  • Gemcitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved